Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lodia Nutrition develops and markets scientifically supported natural ingredients for the dietary supplement and food & beverage industries. Their portfolio includes Norwegian Marine Peptides for blood pressure support, CETO3® (cetoleic acid/Omega 11 & Omega 3), pharmaceutical-grade methyl folate as a bioactive alternative to folic acid, Lactium® for stress management/sleep improvement, and vegan algal DHA through partnerships. The company is active in commercializing these ingredients via global strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lodia Nutrition.